Scientist, Clinical Epidemiology Program
Ottawa Hospital Research Institute

Assistant Professor, Department of Anesthesiology and Pain Medicine
The University of Ottawa

My group is interested in optimizing preclinical to clinical translation - i.e. "bench-to-bedside". At the bench we believe this can be accomplished by improving methodological rigour and promoting transparent reporting. Moving to the bedside we believe that interdisciplinary teams,  including patients and other stakeholders, will help prevent failures and improve efficiency of translation.

We are particularly interested in cell therapies (e.g. mesenchymal stem cells, chimeric antigen receptor T-cells) that may be useful for cancer and cardiovascular disease.

I am a new Associate Scientist appointed to the Ottawa Hospital Research Institute Clinical Epidemiology and Regenerative Medicine Programs. I am also an Assistant Professor (uOttawa) in the Department of Anesthesiology and Pain Medicine and a staff Anesthesiolgist at The Ottawa Hospital. Prior to medical school I completed a B.Sc. (Hons) and Ph.D. in Pharmacology at the University of Alberta.

Blood cancer; COVID-19; Heart disease; Stroke; Vascular, heart and metabolic disease

Anesthesiology; Basic research; Cell therapy; Clinical research; Clinical trials; Disease models; Health research methods; Model organisms; Patient engagement; Regenerative medicine; Stem cells; Translational research